Stockscreener 앱 받기
3.32
1.53%
0.05
시간 외 거래:
3.30
-0.02
-0.60%
전일 마감가:
$3.27
열려 있는:
$3.24
하루 거래량:
4.01M
Relative Volume:
0.89
시가총액:
$1.17B
수익:
$6.31M
순이익/손실:
$-246.87M
주가수익비율:
-2.3701
EPS:
-1.4008
순현금흐름:
$-75.62M
1주 성능:
+1.22%
1개월 성능:
-26.39%
6개월 성능:
-11.47%
1년 성능:
+85.47%
1일 변동 폭
$3.11
$3.36
1주일 범위
$3.11
$3.64
52주 변동 폭
$1.11
$5.465
Precigen Inc Stock (PGEN) Company Profile
명칭
Precigen Inc
전화
301-556-9900
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
3.32 | 1.16B | 6.31M | -246.87M | -75.62M | -1.4008 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-15 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-03-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 개시 | JP Morgan | Neutral |
| 2022-11-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-25 | 개시 | Stifel | Buy |
| 2021-02-22 | 개시 | Wells Fargo | Overweight |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-05-08 | 개시 | H.C. Wainwright | Buy |
모두보기
Precigen Inc 주식(PGEN)의 최신 뉴스
Precigen Stock Hits Day Low of $3.94 Amid Price Pressure - Markets Mojo
Precigen (PGEN) insider exercises 143,678 RSUs into common stock - Stock Titan
Director Frank Steven converts 71,839 RSUs into Precigen (PGEN) common stock - Stock Titan
Precigen (PGEN) director converts 71,839 RSUs into common stock, now holding 305,776 shares - Stock Titan
Director at Precigen (PGEN) converts 71,839 vested RSUs into shares - Stock Titan
[Form 4] PRECIGEN, INC. Insider Trading Activity - Stock Titan
Precigen (PGEN) director exercises RSUs, adds 71,839 common shares - Stock Titan
RSU vesting gives Precigen (PGEN) director 71839 new common shares - Stock Titan
RSU vesting adds 71,839 shares to Precigen (PGEN) director’s holdings - Stock Titan
Precigen, Inc. Hits Day High with Strong 7.01% Intraday Surge - Markets Mojo
Boxer Capital Management LLC Makes New $2.80 Million Investment in Precigen, Inc. $PGEN - MarketBeat
Cantor Fitzgerald Reaffirms Overweight Rating on Precigen (PGEN) - MSN
Precigen (NASDAQ:PGEN) Stock Price Up 7.5%Should You Buy? - MarketBeat
Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25 - The Malaysian Reserve
Is Precigen (PGEN) Reflecting Its Recent Surge Despite Steep Short Term Pullback - simplywall.st
Assessing Precigen (PGEN) Valuation After Recent Share Price Weakness And Conflicting Fair Value Estimates - Yahoo Finance
Randal Kirk (PGEN) reports new Precigen equity awards and large indirect stake - Stock Titan
PRECIGEN (PGEN) director granted RSUs, stock options and shares as compensation - Stock Titan
Precigen (PGEN) director granted RSUs, options and shares as board pay - Stock Titan
Director at Precigen (NASDAQ: PGEN) granted stock, RSUs and options - Stock Titan
PRECIGEN (PGEN) director Vinita Gupta receives RSUs, stock options and shares - Stock Titan
Director at Precigen (NASDAQ: PGEN) receives stock, RSUs and options - Stock Titan
Precigen (PGEN) director awarded stock, RSUs and options as board fees - Stock Titan
Precigen (PGEN) director granted RSUs, stock options and shares as retainer - Stock Titan
Precigen (NASDAQ:PGEN) Upgraded at Zacks Research - MarketBeat
Precigen to Announce Full Year 2025 Financial Results - National Today
Biotech firm Precigen schedules March 25 call on 2025 results - Stock Titan
Precigen (PGEN) to Release Quarterly Earnings on Wednesday - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Given Average Rating of "Hold" by Brokerages - MarketBeat
Gainers Report: Is Precigen Inc forming a bullish divergence2025 Geopolitical Influence & Weekly Setup with High ROI Potential - baoquankhu1.vn
Precigen earnings in focus as gene therapy revenue ramps up By Investing.com - Investing.com Canada
Precigen earnings in focus as gene therapy revenue ramps up - Investing.com
Precigen (PGEN) Surged Following the Early Approval of Papziemos - Insider Monkey
EV Market: Is Precigen Inc stock influenced by commodity prices2025 Investor Takeaways & Technical Pattern Alert System - baoquankhu1.vn
PGEN Stock Price, Quote & Chart | PRECIGEN INC (NASDAQ:PGEN) - ChartMill
Precigen, Inc. (PGEN) Stock Analysis: Unveiling A 123% Upside Potential In Biotech - DirectorsTalk Interviews
Lansing Street Advisors Takes $1.80 Million Position in Precigen, Inc. $PGEN - MarketBeat
Precigen (NASDAQ:PGEN) Share Price Passes Below Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Aug Update: Can Precigen Inc beat the S P 5002025 Winners & Losers & Safe Capital Growth Tips - baoquankhu1.vn
Precigen, Inc. Hits Day Low of $4.04 Amid Price Pressure - Markets Mojo
Precigen, Inc. Experiences Evaluation Revision Amidst Mixed Market Performance Indicators - Markets Mojo
Precigen, Inc. (PGEN): Investor Outlook On A Biotech With 88% Potential Upside - DirectorsTalk Interviews
Why analysts remain bullish on Precigen Inc. stockMarket Growth Report & Advanced Technical Analysis Signals - mfd.ru
Key Takeaways - StocksToTrade
Precigen (NASDAQ:PGEN) Shares Down 6%What's Next? - MarketBeat
Strategic Moves Boost PGEN Momentum Amidst Market Shifts - StocksToTrade
Precigen (NASDAQ:PGEN) Hits New 12-Month HighHere's What Happened - MarketBeat
Can Precigen Translate PAPZIMEOS Momentum Into Revenue Growth And Shareholder Gains? - RTTNews
Precigen (NASDAQ:PGEN) Trading 5.2% HigherStill a Buy? - MarketBeat
Precigen stock hits 52-week high at 5.23 USD - Investing.com
Commit To Buy Precigen At $4, Earn 26.2% Using Options - Nasdaq
Precigen Inc (PGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):